The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medicine, together with the GLP-1 medicines Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
